Faqs

Faqs | Symbiosis Group

1. What is Open Access?

Open Access system provides readers with unrestricted access, use and reproduction of peer-reviewed scholarly journal articles free-of-charge.

2. What is Symbiosis?

Symbiosis aims to offer feature rich solutions on diverse platforms catering researchers, corporate and end users. Explore our website for more brilliant and distinct resources.

3. Why choose Symbiosis?

Symbiosis Open Access publishes peer-reviewed open-access journals in medical, clinical, pharma, engineering and life sciences. Each journal follows state-of-the art review process managed by editor-in-chief and editors who are renowned in their fields. We are committed to a 'rigorous peer-reviewed editorial process' and continually strive to attain the highest standards for excellence in the articles published and their accessibility to the global readers.

4. What are my roles as an Editor?

• Initial review of the articles.
• Assigning reviewers to the articles received.
• Managing the whole review process of the articles assigned.
• Ensuring the quality of articles published.
• Suggesting colleagues and scientists who are experts in the field to submit papers.

5. How do I submit my paper to SOJ?
6. I would be glad to write an article. Is there any particular topic that you would like me to write?

The article can be written on any topic of your interest that falls within the scope of the journal.

7. What is the duration for publishing an article?

The duration for publication of manuscript is within two months.

8. What benefits I get if I were a reviewer?

As a reviewer, you can gain certificate of scientific credits towards the end of year by Editor-in-chief of the corresponding journal. You can also publish your articles without any publication fee, if you can review a minimum of 6 papers.

9. How can I track my paper?
10. What is the word limit for writing articles?

There is no word limit for writing articles.

11. Is there any page limit for the editorial?

Yes, there is a three page limit for editorials

12. What kind of manuscripts do you publish?

Symbiosis Open Access will publish all types of research/review, case reports, short communications, surgeon's reports, letter to editors, thesis and editorials.

13. When I should pay the publication charge?

You can pay the publication charge when your article gets accepted for publication.

14. Will there be color figure charges or additional page charges if my paper exceeds a certain length?

There will be no extra charges for color figures or if the page limit gets exceeded.

15. How long is the review process?

The review process varies from journal to journal but all journals aim to have an efficient peer review and production process to facilitate rapid publication.

Pubmed Indexed Articles

  • Whole Grains in Amelioration of Metabolic Derangements

  • Iron Supplementation Alters Heme and Heme Oxygenase 1 (HO-1) Levels In Pregnant Women in Ghana

  • Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells

  • Evaluation of Patients Knowledge Regarding Smoking and Chronic Pancreatitis: A Pilot Study.

  • Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients.

  • Predicted vs. Actual Resting Energy Expenditure and Activity Coefficients: Post-Gastric Bypass, Lean and Obese Women.

  • Similar Outcomes for Two Anemia Treatment Strategies among Elderly Hemodialysis Patients with Diabetes.

  • Elevation of Cardiac Troponins in Prolonged Status Epilepticus: A Retrospective Chart Analysis.

  • Low-Temperature Trapping of Photointermediates of the Rhodopsin E181Q Mutant.

  • Effects of Long-Term Supplementation of Blue-Green Algae on Lipid Metabolism in C57BL/6J mice.

  • Challenges to Recruitment of Urban African American Patients with Cancer Pain.

  • Measurement of Fractional Exhaled Nitric Oxide as a Marker of Disease Activity in Inflammatory Bowel Disease.

  • Food Additive P-80 Impacts Mouse Gut Microbiota Promoting Intestinal Inflammation, Obesity and Liver Dysfunction.

  • A Review of Mitochondrial-derived Fatty Acids in Epigenetic Regulation of Obesity and Type 2 Diabetes.

  • Fitness Level is Associated with Sex-Specific Regional Fat Differences in Normal Weight Young Adults.

  • Topiramate Protects Pericytes from Glucotoxicity: Role for Mitochondrial CA VA in Cerebromicrovascular Disease in Diabetes.

  • The Vibrio cholerae ToxR Regulon Encodes Host-Specific Chemotaxis Proteins that Function in Intestinal Colonization.

  • Anti-Fibrotic Potential of All Trans Retinoic Acid in Inflammatory Bowel Disease

  • Deficiency in Heat Shock Factor 1 (HSF-1) Expression Exacerbates Sepsis-induced Inflammation and Cardiac Dysfunction

  • Responsiveness of Physical Activity Measures Following Exercise Programs after Total Knee Arthroplasty

  • A T cell equation as a conceptual model of T cell responses for maximizing the efficacy of cancer immunotherapy.

  • Endoscopic Ultrasound-Guided Fine Needle Aspiration Accurately Diagnoses Smaller Pancreatic Neuroendocrine Tumors Compared To Computer Tomography-Guided Fine Needle Aspiration.

  • Prevalence and Social Determinants of Type 2 Diabetes in a Coastal Area of Kerala, India

  • Confronting Complacency in the Face of Calamity: Mobilizing for the Home Front War against Diabetes

  • Healthy Hunger-Free Kids Act Increases Phytochemicals in Menus and Curriculum Furthers Identification of Phytochemical-Rich Foods

  • The Inflammatory Cytokine IL-21 is Expressed by Splenic Neutrophils in Response to Transplantation of Allogeneic Cells.

  • Thyroid Hormone Resistance in Identical Twin Sisters with Atrial Fibrillation: Case Report and Review of the Literature.

  • Circulating Neurotoxic 5-HT2A Receptor Agonist Autoantibodies in Adult Type 2 Diabetes with Parkinson's Disease.

  • Diabetes Autoantibodies Mediate Neural- and Endothelial Cell- Inhibitory Effects Via 5-Hydroxytryptamine- 2 Receptor Coupled to Phospholipase C/Inositol Triphosphate/Ca2+ Pathway

  • Increased Neuronal Depolarization Evoked by Autoantibodies in Diabetic Obstructive Sleep Apnea: Role for Inflammatory Protease(s) in Generation of Neurotoxic Immunoglobulin Fragment.

  • Toxic Immunoglobulin Light Chain Autoantibodies are Associated with a Cluster of Severe Complications in Older Adult Type 2 Diabetes.

  • Autoantibodies in Human Diabetic Depression Inhibit Adult Neural Progenitor Cells In vitro and Induce Depressive-Like Behavior in Rodents.

  • Type 2 Diabetes Predicts Increased Risk of Neurodegenerative Complications in Veterans Suffering Traumatic Brain Injury
  • 31828222


    Download
    Symbiosis_Broucher

    Click on the icon to download the brochure

    TOP